Skip to main content

‘Imitinef Mercilet’ curing Blood Cancer!! Hoax


I just received a mail in the mail Which is is as follows:
 Dear All,

Please send to your colleagues and friends as many you can. Do not delete without sending to anybody.
I have forwarded it to the maximum I can.
Let it reach the 110 crores Indians and the remaining if any.
‘Imitinef Mercilet’ is a medicine which cures blood cancer. Its available free of cost at “Adyar Cancer Institute in Chennai”. Create Awareness. It might help someone.  
Forward to as many as u can, kindness costs  nothing.
Just revealing a fact about this.

Please don’t forward this without being ignorant as this seems to be a hoax. This seemed too good to be true so I googled a little and found out the following:

According to this message, India’s Adyar Cancer Institute is distributing, free of charge, a medicine named ‘Imitinef Mercilet’ that cures blood cancer. The message is circulating rapidly via email and is also making its way around the Internet via blogs, forums and social networking websites.
The Adyar Cancer Institute is a real health facility located in the city of Chennai, India and, as its name implies, it indeed specializes in cancer treatment and research. The Adyar Cancer Institute has achieved great results in the treatment and research of cancer since its establishment in 1954.
I contacted a spokesperson at the Adyar Cancer Institute to ask about the veracity of the message. He sent me the following reply:
Only the Part of this message is true. The medicine Imitinef is available free for only qualified persons and not for all. It is free for those who have admitted in the hospital for treatment.
‘Imitinef Mercilet’ is apparently an alternative spelling of the drug Imatinib mesylate which is used in the treatment of some forms of leukemia along with other types of cancer. Imatinib, often referred to a “Gleevec”, has proved to be an effective treatment for some forms of cancers. However, “blood cancer” is a generalized term for cancers that affect the blood, lymphatic system or bone marrow. The three types of blood cancer are listed as leukemia, lymphoma, and multiple myeloma. These three malignancies require quite different kinds of treatments. While drugs (including Imatinib), along with other treatments such as radiation can help to slow or even stop the progress of these cancers, there is currently no single drug treatment that can be said to actually cure all such cancers.
Moreover, it should be noted that Imatinib is available for cancer patients in many different health facilities around the world, not just the Adyar Cancer Institute.
Thus, although there are some elements of truth to this message, its is also potentially misleading and contains inaccurate information.
According to this message, India’s Adyar Cancer Institute is distributing, free of charge, a medicine named ‘Imitinef Mercilet’ that cures blood cancer. The message is circulating rapidly via email and is also making its way around the Internet via blogs, forums and social networking websites.
The Adyar Cancer Institute is a real health facility located in the city of Chennai, India and, as its name implies, it indeed specializes in cancer treatment and research. The Adyar Cancer Institute has achieved great results in the treatment and research of cancer since its establishment in 1954.
I contacted a spokesperson at the Adyar Cancer Institute to ask about the veracity of the message. He sent me the following reply:
Only the Part of this message is true. The medicine Imitinef is available free for only qualified persons and not for all. It is free for those who have admitted in the hospital for treatment.
‘Imitinef Mercilet’ is apparently an alternative spelling of the drug Imatinib mesylate which is used in the treatment of some forms of leukemia along with other types of cancer. Imatinib, often referred to a “Gleevec”, has proved to be an effective treatment for some forms of cancers. However, “blood cancer” is a generalized term for cancers that affect the blood, lymphatic system or bone marrow. The three types of blood cancer are listed as leukemia, lymphoma, and multiple myeloma. These three malignancies require quite different kinds of treatments. While drugs (including Imatinib), along with other treatments such as radiation can help to slow or even stop the progress of these cancers, there is currently no single drug treatment that can be said to actually cure all such cancers.
Moreover, it should be noted that Imatinib is available for cancer patients in many different health facilities around the world, not just the Adyar Cancer Institute.
Thus, although there are some elements of truth to this message, its is also potentially misleading and contains inaccurate information.
Labels:

Comments

Post a Comment

Popular posts from this blog

Racecraft (Project Koru) · Prologue — The Origin Story

Racecraft · Prologue , The Origin Story It Started With a Wine List and a Question About Racing How a happy-hour conversation in the Bay Area turned into a trustable AI race coach , and then into a second version that runs entirely on a phone, on the NPU. This is the prologue to a five-part series. Two years ago(1st November, 2024) I was in the Bay Area for a GDE Summit. If you've never been: it's a couple of days of talks among Google Developer Experts, the kind of people who get unreasonably excited about a new on-device runtime, and then , mercifully , a happy hour where everyone stops performing and just eats. We ended up at a restaurant(Puesto Santa Clara), a long table of GDEs, and I was doing the most important engineering of the evening: trying to decide which wine to order. Across the table was Ajeet Mirwani . I don't even remember how the wine talk turned into racing talk , these things drift , but the moment the word "racing" ...
Post a Comment
Read more

A Split‑Brain Neuro‑Symbolic Training Method for High‑Velocity Autonomous Coaching from Telemetry

 Author: Rabimba Karanjai Scope: Problem statement + data methodology + model training (no deployment discussion) Abstract Real‑time coaching in motorsport is a safety‑critical learning problem : a system must map noisy, high‑frequency telemetry to short, actionable guidance that remains physically consistent and avoids hazardous recommendations . This paper proposes a “Split‑Brain” training formulation that separates (i) a semantic coaching target (what action/critique should be expressed) from (ii) a reflexive interface (how actions are represented as compact, verifiable tokens). The approach trains a Small Language Model (SLM) in the Gemma family [1] using QLoRA fine‑tuning [2] , and introduces a telemetry tokenizer plus teacher‑student synthesis pipeline to generate instruction‑action pairs at scale. Core contribution: a reproducible method to convert “ golden lap ” differential tel...
Post a Comment
Read more

My Friend's MRI Didn't Come with a Manual, So I Built One with AI

Gemma 4 Good Hackathon · Impact Track · Health & Sciences It started with two envelopes. One contained a single sheet of paper, a radiologist's report for my friend. It was a wall of text that might as well have been written in another language. Words like " parenchymal volume ," " hyperintensities ," and " susceptibility artifact " stared back at us, creating more anxiety than they resolved. The other was a flimsy paper sleeve containing a CD-ROM. This, we were told, held the actual images from her MRI scan. The ground truth. And we couldn't even look at it. Our laptops, like most these days, don't have disc drives. For a moment, this crucial, deeply personal piece of her health information was a coaster. I felt that familiar, hot-wired frustration every engineer knows: the feeling of being locked out by a dumb problem. The powerlessness was infuriating. So, I did what any slightly obsessive software engineer would do...
Post a Comment
Read more